O'Malley Brendan M. 4

What Happened
Brendan O'Malley, Senior Vice President and Chief Legal Officer of Abeona Therapeutics (ABEO), sold 12,050 shares in an open-market transaction on July 9, 2026. The reported weighted-average price was $6.96 per share, for aggregate proceeds of approximately $83,913. The filing notes the sales were to cover tax obligations tied to the vesting of restricted stock awards.

Key Details

• Transaction date: 2026-07-09
• Transaction type/code: Sale (S) — open-market sell(s) to cover taxes (sell-to-cover)
• Shares sold: 12,050
• Price: weighted-average $6.96; individual trades ranged from $6.86 to $7.04 (footnote)
• Proceeds: ~$83,913
• Reason given: to cover tax obligations from vesting of restricted stock awards (footnote F1)
• Additional note: price shown is a weighted average; reporting person can provide per-price breakdown on request (footnote F2)
• Filing timeliness: Reported with a Period of Report equal to the transaction date and filed the same day — not indicated as late

Context
This was a sell-to-cover following vesting, which is a routine administrative transaction and not necessarily an indicator of the insider’s view on the company. Purchases typically carry more direct signaling value than routine sales. If you want the exact number of shares sold at each price within the stated range, the filer has offered to provide that breakdown upon request (per footnote).